Pelosi E - Search Results

1

Artificial intelligence for reduced dose 18F-FDG PET examinations: a real-world deployment through a standardized framework and business case assessment.

Katsari K, Penna D, Arena V, Polverari G, Ianniello A, Italiano D, Milani R, Roncacci A, Illing RO, Pelosi E. Katsari K, et al. Among authors: pelosi e. EJNMMI Phys. 2021 Mar 9;8(1):25. doi: 10.1186/s40658-021-00374-7. EJNMMI Phys. 2021. PMID: 33687602 Free PMC article.

2

FDG-PET in the detection of bone marrow disease in Hodgkin's disease and aggressive non-Hodgkin's lymphoma and its impact on clinical management.

Pelosi E, Penna D, Deandreis D, Chiappella A, Skanjeti A, Vitolo U, Bisi G. Pelosi E, et al. Q J Nucl Med Mol Imaging. 2008 Mar;52(1):9-16. Q J Nucl Med Mol Imaging. 2008. PMID: 18235420 Free article.

3

Fluorodeoxyglucose-positron emission tomography/computed tomography in the staging and evaluation of treatment response in a patient with Castleman's disease: a case report.

Pelosi E, Skanjeti A, Cistaro A, Arena V. Pelosi E, et al. J Med Case Rep. 2008 Apr 3;2:99. doi: 10.1186/1752-1947-2-99. J Med Case Rep. 2008. PMID: 18387191 Free PMC article.

4

Role of whole-body [18F] fluorodeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT) and conventional techniques in the staging of patients with Hodgkin and aggressive non Hodgkin lymphoma.

Pelosi E, Pregno P, Penna D, Deandreis D, Chiappella A, Limerutti G, Vitolo U, Mancini M, Bisi G, Gallo E. Pelosi E, et al. Radiol Med. 2008 Jun;113(4):578-90. doi: 10.1007/s11547-008-0264-7. Epub 2008 Apr 14. Radiol Med. 2008. PMID: 18414808 English, Italian.

5

Role of whole-body 18F-choline PET/CT in disease detection in patients with biochemical relapse after radical treatment for prostate cancer.

Pelosi E, Arena V, Skanjeti A, Pirro V, Douroukas A, Pupi A, Mancini M. Pelosi E, et al. Radiol Med. 2008 Sep;113(6):895-904. doi: 10.1007/s11547-008-0263-8. Epub 2008 Apr 14. Radiol Med. 2008. PMID: 18414809 English, Italian.

6

Dual-phase FDG-PET: delayed acquisition improves hepatic detectability of pathological uptake.

Arena V, Skanjeti A, Casoni R, Douroukas A, Pelosi E. Arena V, et al. Among authors: pelosi e. Radiol Med. 2008 Sep;113(6):875-86. doi: 10.1007/s11547-008-0287-0. Epub 2008 Jul 10. Radiol Med. 2008. PMID: 18618076 English, Italian.

7

Detection of metastatic involvement of the pericardium on F-18 FDG-PET/CT imaging.

Douroukas A, Arena V, Pelosi E. Douroukas A, et al. Among authors: pelosi e. Clin Nucl Med. 2009 Jan;34(1):40-1. doi: 10.1097/RLU.0b013e31818f4495. Clin Nucl Med. 2009. PMID: 19092385 No abstract available.

8

Prognostic role of the PET parameter maximum standardized uptake value in non small cell lung cancer: analysis in tumour of diameter ≥ and <25 mm.

Pelosi E, Billè A, Skanjeti A, Errico L, Arena V, Ardissone F, Borasio P, Mancini M. Pelosi E, et al. Q J Nucl Med Mol Imaging. 2011 Feb;55(1):72-80. Epub 2010 Jun 11. Q J Nucl Med Mol Imaging. 2011. PMID: 20539268

9

Bone marrow disease detection with FDG-PET/CT and bone marrow biopsy during the staging of malignant lymphoma: results from a large multicentre study.

Pelosi E, Penna D, Douroukas A, Bellò M, Amati A, Arena V, Passera R, Bisi G. Pelosi E, et al. Q J Nucl Med Mol Imaging. 2011 Aug;55(4):469-75. Epub 2010 Dec 9. Q J Nucl Med Mol Imaging. 2011. PMID: 21150862

10

Role of integrated PET/CT with [¹⁸F]-FDG in the management of patients with fever of unknown origin: a single-centre experience.

Pelosi E, Skanjeti A, Penna D, Arena V. Pelosi E, et al. Radiol Med. 2011 Aug;116(5):809-20. doi: 10.1007/s11547-011-0649-x. Epub 2011 Mar 7. Radiol Med. 2011. PMID: 21424320

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

293 results

Search Page

Filters